The International Prostate Symptom Score (IPSS), a ubiquitous clinical assessment tool, is a standard in the assessment and research of lower urinary tract symptoms in men. Continue reading “International Prostate Symptom Score (IPSS)”
The International Prostate Symptom Score (IPSS), a ubiquitous clinical assessment tool, is a standard in the assessment and research of lower urinary tract symptoms in men. Continue reading “International Prostate Symptom Score (IPSS)”
PI-RADS is designed to improve focal lesion detection, localization, characterization, and risk stratification in patients with suspected cancer and consists of technical recommendation for MRI acquisition and a scoring system for image interpretation. PI-RADS uses a scale of 1–5 to report the overall probability of clinically significant prostate cancer on multiparametric MRI (mpMRI). The use of PI-RADS is limited to treatment naive patients and it should not be used for staging, assessment of treatment outcome, recurrence, or progression during surveillance.
Continue reading “Prostate Imaging Reporting And Data System (PI-RADS)”
The rationale for screening is that early detection and treatment of asymptomatic cancers could extend life, as compared with treatment at the time of clinical diagnosis. The introduction of prostate-specific antigen (PSA) testing has nearly doubled the lifetime risk of receiving a diagnosis of prostate cancer.
Continue reading “Prostate-Cancer Screening Guidelines”
The Tumor-Node-Metastasis (TNM) System
Copyright by MedicalCriteria.com